The New England journal of medicine
The most recent articles from:
N. Engl. J. Med.
2021
-
Editorial Comment
STEP 1 for Effective Weight Control - Another First Step?
-
Randomized Controlled Trial Multicenter Study
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed. ⋯ In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight. (Funded by Novo Nordisk; STEP 1 ClinicalTrials.gov number, NCT03548935).